C. Vitte et al., BIPHOSPHONATES INDUCE OSTEOBLASTS TO SECRETE AN INHIBITOR OF OSTEOCLAST-MEDIATED RESORPTION, Endocrinology, 137(6), 1996, pp. 2324-2333
Current knowledge indicates that osteoblasts play an integral role in
osteoclastic bone resorption through an osteoclast-stimulating activit
y produced by osteoblasts in response to resorption-promoting osteotro
pic factors. Previously, we have shown that the inhibitory action of t
he bisphosphonates on bone resorption in part is mediated by osteoblas
ts. The aim of the present study was to investigate whether the biphos
phonate-generated inhibition is due to these compounds decreasing the
synthesis of the osteoclast-stimulating activity or is the result of o
steoblasts synthesizing an osteoclast resorption inhibitor. Using the
osteoblastic cell line CRP 10/30, which produces osteoclast-stimulatin
g activity, constitutively and employing isolated rat osteoclasts cult
ured on ivory, evidence was obtained indicating that the biphosphonate
s ibandronate and alendronate at a concentration of 10(-7) M induce os
teoblasts to synthesize an osteoclast inhibitor that reduces pit forma
tion by more than 50%. The inhibitor is heat and proteinase labile and
has a molecular mass between 1-10 kDa. The reduction of resorption pi
ts is paralleled by a decrease in tartrate-resistant acid phosphatase-
positive mono- and multinucleated cells, whereas the mean area resorbe
d per pit was not changed, suggesting that the inhibitor affects osteo
clast formation and/or survival and probably not the osteoclast resorp
tion activity. Rat preosteoblastic cells and rat dermal fibroblasts we
re found not to produce the inhibitor. In conclusion, osteoblasts asid
e from their role of mediating osteoclastic resorption promoters are a
lso involved in inhibiting bone resorption through the synthesis of an
osteoclast resorption inhibitor.